OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.710
+0.050 (3.01%)
Mar 9, 2026, 4:00 PM EDT - Market closed

OKYO Pharma Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Net Income
-4.61-4.71-16.83-13.27-5.43-3.35
Upgrade
Depreciation & Amortization
000000.01
Upgrade
Loss (Gain) From Sale of Assets
-----0-0
Upgrade
Stock-Based Compensation
1.361.411.131.321.80.63
Upgrade
Other Operating Activities
2.4-0.153.530.31-0.810.05
Upgrade
Change in Accounts Receivable
0.02---0.03-0
Upgrade
Change in Accounts Payable
-1.471.722.233.78-0.250.84
Upgrade
Change in Other Net Operating Assets
-0.8-0.090.440.17-0.80.21
Upgrade
Operating Cash Flow
-3.1-1.81-9.49-7.7-5.47-1.6
Upgrade
Capital Expenditures
-0-0--0.01-0-0.01
Upgrade
Other Investing Activities
------0.01
Upgrade
Investing Cash Flow
-0-0--0.01-0-0.02
Upgrade
Short-Term Debt Issued
---2--
Upgrade
Long-Term Debt Issued
-0.95---7.59
Upgrade
Total Debt Issued
0.950.95-2-7.59
Upgrade
Long-Term Debt Repaid
------0.01
Upgrade
Net Debt Issued (Repaid)
0.950.95-2-7.58
Upgrade
Issuance of Common Stock
5.471.716.217.322.150.25
Upgrade
Financing Cash Flow
6.422.666.219.322.157.83
Upgrade
Foreign Exchange Rate Adjustments
-0.09-0.110.06-0.28-0.870.45
Upgrade
Miscellaneous Cash Flow Adjustments
-----0
Upgrade
Net Cash Flow
3.230.73-3.221.34-4.196.65
Upgrade
Free Cash Flow
-3.1-1.81-9.49-7.7-5.47-1.61
Upgrade
Free Cash Flow Per Share
-0.07-0.05-0.32-0.35-0.36-0.15
Upgrade
Cash Income Tax Paid
--2--0.2--0.08
Upgrade
Levered Free Cash Flow
-3-2.72-3.09-2.77-3.9-0.31
Upgrade
Unlevered Free Cash Flow
-2.88-2.18-2.44-2.71-3.9-0.31
Upgrade
Change in Working Capital
-2.251.632.673.95-1.021.04
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.